Aug. 31 at 2:06 PM
The Court Finally Approved the
$6M Settlement Between Gritstone bio and Its Investors over Delayed COVID-19 Vaccine Study
The case alleged that Gritstone bio misled investors about the timing of its CORAL Phase 2b COVID-19 vaccine study and related BARDA funding. In 2024, the company delayed the study and then announced a 40% workforce reduction, sending
$GRTS down nearly 28%.
With the settlement now approved, eligible investors may be able to submit a claim: https://11th.com/cases/gritstone-investor-settlement